Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer

High Risk ◽

Cell Transplantation ◽

Induction Chemotherapy ◽

Peripheral Blood ◽

Progenitor Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose

Immunotherapy following high-dose chemotherapy (HDCT) and peripheral blood progenitor cell transplantation (PBPCT) in the treatment of high-risk early breast cancer (HREBC) and metastatic breast cancer (MBC).

10.1158/0008-5472.sabcs-2159 ◽

2009 ◽

Author(s):

F Recchia ◽

G Candeloro ◽

S Necozione ◽

M Sureda ◽

A Brugarolas ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Cell Transplantation ◽

Early Breast Cancer ◽

Peripheral Blood ◽

Progenitor Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose

Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-003-0449-3 ◽

2003 ◽

Vol 129 (6) ◽

pp. 361-366 ◽

Author(s):

Herbert G. Sayer ◽

Kristina Schilling ◽

Tobias Vogt ◽

Kerstin Blumenstengel ◽

Miriam Charbel Issa ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Blood Stem Cell Transplantation

Detection by means of RT-PCR of micrometastases in the peripheral blood, bone marrow and leukapheresis products in women with breast cancer, selected for high-dose chemotherapy and peripheral blood progenitor cell transplantation

European Journal of Cancer ◽

10.1016/s0959-8049(98)80301-8 ◽

1998 ◽

Vol 34 ◽

pp. S73

Author(s):

G. Merla ◽

S. Papa ◽

M. Aicta ◽

A. Tartarone ◽

R. Murgo ◽

...

Keyword(s):

Breast Cancer ◽

Bone Marrow ◽

Cell Transplantation ◽

Peripheral Blood ◽

Progenitor Cell ◽

High Dose Chemotherapy ◽

High Dose ◽

Rt Pcr

High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1703274 ◽

2001 ◽

Vol 28 (11) ◽

pp. 1023-1029 ◽

Author(s):

JL Klein ◽

C Hamm ◽

RD Dansey ◽

C Karanes ◽

E Abella ◽

...

Keyword(s):

Breast Cancer ◽

Bone Marrow ◽

Cell Transplantation ◽

Peripheral Blood ◽

Progenitor Cell ◽

High Dose Chemotherapy ◽

High Dose

Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancer

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1703066 ◽

2001 ◽

Vol 27 (12) ◽

pp. 1245-1253 ◽

Cited By ~ 3

Author(s):

AL Pecora ◽

HM Lazarus ◽

EA Stadtmauer ◽

J Winter ◽

A Van Vliet ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Induction Chemotherapy ◽

Stem Cell Transplant ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

Autologous Stem Cell Transplant ◽

High Dose ◽

Cell Transplant

Epirubicin-containing high-dose chemotherapy followed by autologous hematopoietic progenitor cell transfusion for patients with chemotherapy-sensitive metastatic breast cancer: results of 5-year follow-up

Cancer Chemotherapy and Pharmacology ◽

10.1007/s002800050856 ◽

1999 ◽

Vol 43 (1) ◽

pp. 8-12 ◽

Cited By ~ 3

Author(s):

Yoshinori Ito ◽

Taketo Mukaiyama ◽

Makoto Ogawa ◽

Nobuyuki Mizunuma ◽

Shunji Takahashi ◽

...

Keyword(s):

Breast Cancer ◽

Progenitor Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

Hematopoietic Progenitor Cell ◽

High Dose ◽

Hematopoietic Progenitor

Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer

Hematology/Oncology and Stem Cell Therapy ◽

10.1016/j.hemonc.2015.06.005 ◽

2015 ◽

Vol 8 (3) ◽

pp. 115-124 ◽

Cited By ~ 1

Author(s):

Betty Ky Hamilton ◽

Lisa Rybicki ◽

Donna Abounader ◽

Steven Andresen ◽

Matt Kalaycio ◽

...

Keyword(s):

Breast Cancer ◽

Autologous Hematopoietic Cell Transplantation

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Term Survival ◽

High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study

British Journal of Cancer ◽

10.1038/bjc.1996.669 ◽

1996 ◽

Vol 74 (12) ◽

pp. 2013-2017 ◽

Author(s):

DA Cameron ◽

◽

J Craig ◽

H Gabra ◽

L Lee ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Progenitor Cells ◽

Peripheral Blood ◽

Poor Prognosis ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Peripheral Blood Progenitor Cells

Factors Influencing Collection and Engraftment of CD34+Cells in Patients with Breast Cancer Following High-Dose Chemotherapy and Autologous Peripheral Blood Progenitor Cell Transplantation

Journal of Hematotherapy & Stem Cell Research ◽

10.1089/152581600319685 ◽

2000 ◽

Vol 9 (1) ◽

pp. 103-109 ◽

Author(s):

Miguel A. Canales ◽

Rosario Arrieta ◽

M. Carmen Hernandez-Garcia ◽

Emilio Ojeda ◽

Jesus Diez ◽

...

Keyword(s):

Breast Cancer ◽

Cell Transplantation ◽

Peripheral Blood ◽

Progenitor Cell ◽

High Dose Chemotherapy ◽

High Dose ◽

Factors Influencing ◽

Cd34 Cells

Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer

Annals of Oncology ◽

10.1023/a:1008259518263 ◽

1997 ◽

Vol 8 (10) ◽

pp. 957-962 ◽

Cited By ~ 13

Author(s):

A.H. Honkoop ◽

E. van der Wall ◽

N. Feller ◽

G.-J. Schuurhuis ◽

W.J.F. van der Vijgh ◽

...

Keyword(s):

Breast Cancer ◽

Peripheral Blood ◽

Progenitor Cell ◽

Metastatic Breast ◽

High Dose ◽

Multiple Cycles ◽

Mobilized Peripheral Blood ◽

Cell Support